SCHEMBL457994

SCHEMBL457994

Cc1c(C(N)=O)cccc1C1CC1

nearest known ligand 0.42

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
HTR2C P28335 2/20 0.42
PARP1 P09874 10/20 0.41
SLC6A2 P23975 1/20 0.40
SLC6A4 P31645 1/20 0.40
SLC6A3 Q01959 1/20 0.40
OPRK1 P41145 1/20 0.40
KCNH2 Q12809 1/20 0.40
NOTUM Q6P988 2/20 0.39
CD38 P28907 2/20 0.39
CYP2D6 P10635 1/20 0.39
CYP2B6 P20813 1/20 0.39
KDM4E B2RXH2 1/20 0.38
ALDH1A1 P00352 1/20 0.38
MAPT P10636 1/20 0.38
HPGD P15428 1/20 0.38
TSHR P16473 1/20 0.38
HSD17B10 Q99714 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4359674 0.93 KDM4E (0.45) HTR2CPARP1SLC6A2SLC6A4SLC6A3
SCHEMBL27003074 0.92 KDM4E (0.48) HTR2CPARP1CD38CYP2D6CYP2B6
SCHEMBL4141787 0.92 KDM4E (0.48) HTR2CPARP1CD38CYP2D6CYP2B6
SCHEMBL20822490 0.89 PARP1 (0.43) HTR2CPARP1SLC6A2SLC6A4SLC6A3
SCHEMBL3809376 0.89 HTR2C (0.59) HTR2CPARP1
Hydrochloric Acid SCHEMBL27587929 0.88 HTR2C (0.60) HTR2CPARP1
SCHEMBL28793931 0.85 PARP1 (0.49) HTR2CPARP1
SCHEMBL17133909 0.84 GRM7 (0.46) HTR2CNOTUMKDM4EALDH1A1HPGD
SCHEMBL4969775 0.84 NOTUM (0.49) HTR2CSLC6A2SLC6A4SLC6A3NOTUM
SCHEMBL4443008 0.84 HTR2C (0.43) HTR2CNOTUM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2014020041-A1 COMBINATIONS FOR THE TREATMENT OF CANCER BAYER PHARMA AKTIENGESELLSCHAFT (DE) 2014-02-06 WO claimed
EP-2614063-A1 SUBSTITUTED IMIDAZOPYRIDAZINES Bayer Intellectual Property GmbH (DE) 2013-07-17 EP claimed
WO-2012032031-A1 SUBSTITUTED IMIDAZOPYRIDAZINES BAYER PHARMA AKTIENGESELLSCHAFT (DE) 2012-03-15 WO claimed
EP-2878594-A1 DIFLUOROMETHYLENE COMPOUND Sato Pharmaceutical Co., Ltd. (JP) 2015-06-03 EP disclosed
EP-2834237-A1 HETEROCYCLYL COMPOUNDS AS MEK INHIBITORS Lupin Limited (IN) 2015-02-11 EP disclosed
WO-2013136249-A1 HETEROCYCLYL COMPOUNDS AS MEK INHIBITORS LUPIN LIMITED (IN) 2013-09-19 WO disclosed
EP-2614063-A1 SUBSTITUTED IMIDAZOPYRIDAZINES Bayer Intellectual Property GmbH (DE) 2013-07-17 EP disclosed
WO-2012032031-A1 SUBSTITUTED IMIDAZOPYRIDAZINES BAYER PHARMA AKTIENGESELLSCHAFT (DE) 2012-03-15 WO disclosed
EP-2413941-A1 RENIN INHIBITORS Merck Sharp & Dohme Corp. (US) 2012-02-08 EP disclosed
WO-2010114978-A1 RENIN INHIBITORS MERCK SHARP & DOHME CORP. (US) 2010-10-07 WO disclosed
EP-2170848-A1 PYRAZINONE DERIVATIVES AND THEIR USE IN THE TREATMENT OF LUNG DISEASES AstraZeneca AB (SE) 2010-04-07 EP disclosed
WO-2009001132-A1 PYRAZINONE DERIVATIVES AND THEIR USE IN THE TREATMENT OF LUNG DISEASES ASTRAZENECA AB (SE) 2008-12-31 WO disclosed